EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy

Chenming Zhong, Zijun Xie, Shiwei Duan iD

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Chenming Zhong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejia…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Non-Small-Cell Lung, Receptors, Chimeric Antigen, Lung Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To date, standardizing clinical predictive biomarkers for assessing the response to immunotherapy remains challenging due to variations in personal genetic signatures, tumour microenvironment complexities and epigenetic onco‐mechanisms. Main Body Early monitoring of key non‐coding RNA (ncRNA) biomarkers may help in predicting the clinical efficacy of cancer immunotherapy and come up with standard predictive ncRNA biomarkers. For instance, reduced miR‐125b‐5p level in the plasma of non‐small cell lung cancer patients treated with anti‐PD‐1 predicts a positive outcome. The level of miR‐153 in the plasma of colorectal cancer patients treated with chimeric antigen receptor T lymphocyte (CAR‐T) cell therapy may indicate the activation of T‐cell killing activity. miR‐148a‐3p and miR‐375 levels may forecast favourable responses to CAR‐T‐cell therapy in B‐cell acute lymphoblastic leukaemia. In cancer patients treated with the GPC3 peptide vaccine, serum levels of miR‐1228‐5p, miR‐193a‐5p and miR‐375‐3p were reported as predictive biomarkers of good response and improved overall survival. Therefore, there is a critical need for further studies to elaborate on the key ncRNA biomarkers that have the potential to predict early clinical responses to immunotherapy.

Conclusions

This review summarises important predictive ncRNA biomarkers that were reported in cancer patients treated with different immunotherapeutic modalities including monoclonal antibodies, small molecule inhibitors, cancer vaccines and CAR‐T cells. In addition, a concise discussion on forthcoming perspectives is provided, outlining technical approaches for the optimal utilisation of immune‐modulatory ncRNA biomarkers as predictive tools and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, Non-Small-Cell LungReceptors, Chimeric AntigenLung NeoplasmsMicroRNAsAntineoplastic AgentsHumansBiomarkersAutophagyTumor MicroenvironmentGlypicans

Stichwörter der Autor:innen

apoptosisautophagycancerdrug resistancelncRNA

Substanzen

RNA, Long NoncodingReceptors, Chimeric AntigenMicroRNAsBiomarkersAntineoplastic AgentsGPC3 protein, humanGlypicansMIRN153 microRNA, human

Autor:innen und Institutionen

  • Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, P. R. China.
  • Medical Genetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang, P. R. China.

ORCID-Profile: Shiwei Duan

Zitieren

APA

Zhong, C., Xie, Z., & Duan, S. (2023). H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1445

Vancouver

Zhong C, Xie Z, Duan S. H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1445

BibTeX
@article{Zhong2023,
  author = {Zhong, Chenming and Xie, Zijun and Duan, Shiwei},
  title = {H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1445}
}
Kostenlos starten →